Methylene blue

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Methylene blue or methylthioninium chloride (MB) is a medication and dye that also functions as an antioxidant.[1][2][3]

Theory[edit | edit source]

Methylene blue is claimed to lead to better oxygenation of tissues, mitochondrial protection and recovery, improved memory and cognition. It is used sublingually by some ME/CFS patients.

Evidence[edit | edit source]

No clinical trials of methylene blue have been conducted in ME/CFS patients.

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Serotonin syndrome and a number of other serious side effects may result from the use of methylene blue. It also turns skin and mucosa a bluish color and urine a greenish blue color.[2][4]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. "Methylene blue (CHEBI:6872)". Chemical Entities of Biological Interest. Retrieved November 29, 2020.
  2. 2.0 2.1 American Society of Health-System Pharmacists. "Methylene Blue Monograph for Professionals". Drugs.com. Retrieved November 29, 2020.
  3. "Methylene blue". go.drugbank.com. Retrieved November 29, 2020.
  4. Ginimuge, Prashant R.; Jyothi, S.D. (2010). "Methylene Blue: Revisited". Journal of Anaesthesiology, Clinical Pharmacology. 26 (4): 517–520. ISSN 0970-9185. PMC 3087269. PMID 21547182.